This inventor holds 1 USPTO granted patent. Top assignee: Eisai R&d Management Co., Ltd.. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Tohru Arai: Innovator in Mammalian Feeding and Weight Management
Introduction
Tohru Arai is a notable inventor based in Tsukuba, Japan. He has made significant contributions to the field of mammalian biology, particularly in understanding the mechanisms that affect feeding and weight management. His innovative work has led to the development of a patent that addresses important health issues related to obesity and diabetes.
Latest Patents
Tohru Arai holds a patent for "Methods of affecting feeding and weight in mammals by administration of relaxin-3." This invention highlights the feeding-stimulating activity of relaxin-3, which has been observed to increase body weight and fat weight when administered intracerebroventricularly to rats. The patent includes a polypeptide that stimulates feeding, increases body weight, and promotes fattening. Additionally, it encompasses a therapeutic agent containing the polypeptide, methods for screening compounds that interact with the polypeptide's receptor, and agents that inhibit the expression of the polypeptide, which could be beneficial in treating obesity and diabetes.
Career Highlights
Tohru Arai is associated with Eisai R&D Management Co., Ltd., where he continues to advance research in the field of pharmacology and therapeutic development. His work is pivotal in creating solutions for weight management and metabolic disorders.
Collaborations
Tohru Arai has collaborated with notable colleagues such as Takayuki Hida and Tomoko Sekiya. Their combined expertise contributes to the innovative research and development efforts at Eisai R&D Management Co., Ltd.
Conclusion
Tohru Arai's contributions to the understanding of feeding mechanisms and weight management in mammals are significant. His patented work on relaxin-3 offers promising avenues for therapeutic interventions in obesity and diabetes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
